Bob Eulau
Analyst · Goldman Sachs
Okay. Thanks, Jure. Please turn to Slide 3. Overall, the second quarter was below our expectations. Non-GAAP revenue of $1.53 billion was down 8.6% on a sequential basis, but up 3.4% from the second quarter last year. Non-GAAP earnings per share was $0.50 which was at the low end of our guidance for the quarter. This was based on 86.9 million shares outstanding on a fully diluted basis. One bright spot for the quarter was our cash flow from operations which was $70 million; this is up $76 million from the first quarter. During the quarter we used $21.6 million to repurchase approximately 1 million shares of common stocks. We have $103 million in remaining authorizations to repurchase common stocks. I'll discuss cash in more detail in a few minutes. Please turn to Slide 4. From a GAAP perspective, revenue was down 8.6% or $143 million from Q1 to $1.528 billion. We reported net income of $14.7 million, which resulted in diluted earnings per share of $0.17 for the second quarter. This was down relative to last quarter by $0.09. During the quarter we resolved several foreign tax issues, which resulted in a net charge of approximately $10 million including adjustments to related interest expense and foreign exchange. The largest and most unfavorable of these items relates to 2006. We do not currently anticipate other material discrete tax events in the near future. The restructuring costs for Q2 were $1.7 million. These costs were associated with the real estate that we have on the market to be sold. We expect these costs to be in the range of $2 million to $2 million next quarter. Currently we have about $55 million in real estate on the market at list price. During the quarter we sold one building with net proceeds of $5.8 million. My remaining comments will focus on the non-GAAP financials for the second quarter of fiscal year 2015. At $117.2 million, gross profit was down $15 million from the prior quarter. Gross margin came in at 7.7%, which was down 20 basis points from Q1. Both gross profit and gross margin were negatively impacted by the lower revenue in Q2. Operating expenses were down $3.5 million for the quarter at $60.6 million. This represents a 20 basis point increase in operating expenses as a percent of revenue compared to Q1. Spending was down this quarter primarily due to lower accruals for incentive compensation. At $56.6 million, operating income decreased by 17.2% from the prior quarter but increased 6.4% from Q2 last year. Operating margin was 3.7%, which was a 40 basis point sequential decrease. Other income and expense at $6.3 million was up 25% when compared with the last quarter and down 9% from the second quarter last year. The tax rate for the quarter was 13.7% of pretax income, which was lower than we had expected. This decrease was driven by a shift in the mix of profitability to lower tax rate jurisdictions. On a non-GAAP basis we earned $43.4 million in net income or $0.50 per share. Earnings per share were down $0.11 from Q1 and up $0.06 from Q2 last year. On Slide 5 we're showing you some of our key non-GAAP P&L metrics. Revenue was down $143 million or 8.6% from last quarter. Compared to Q2 last year, total revenue was up $51 million or 3.4%. Revenue was down sequentially across all market segments. On a year-over-year basis, there was a substantial increase in our industrial medical and defense segments which continues to be a very good segment for us and is helping us diversify our revenue base. This segment became our largest segment at 39.5% of revenue for the quarter. Moving on to gross profit. Gross margin was lower in Q2 primarily due to the lost contribution on lower revenue in Q1. Gross profit was down $15 million from Q1 and down $3.7 million when compared to Q2 last year. Our operating income decreased 17.2% when compared to a strong first quarter. This led to $56.6 million in operating income, an operating margin of 3.7%. Net interest expense was down $200 thousand to $5.9 million for Q2 when compared to Q1 and down $1.4 million when compared to Q2 last year. Over the last few years, our net interest expense declined considerably as we reduced our debt. At this point we expect that the interest expense continuing at roughly the level of Q2. Please turn to Slide 6. We are providing more information on the segments that we report. As you can see from the graph on the left, the Integrated Manufacturing Solutions segment was down $148 million or 10.8% from last quarter. The decline in revenue led to a 60 basis point decrease in IMS gross margin from Q1. The second segment press is Components, Products and Services. In aggregate, the revenue for this segment was down $11 million or 3.2%, with gross margin up 1.4 percentage points to 10.4%. This gross margin improvement reflects flat profitability in the components area and improved profitability in the Product and Services businesses. Now I'd like to turn your attention to the balance sheet on Slide 7. Our cash and cash equivalents were $408 million. Cash was up $17 million from the previous quarter. Accounts receivable were down $51 million and inventory was down $50 million. These declines were primarily driven by the lower revenue level we had in Q2. Property, plant and equipment was down $12 million for the quarter. From a liability standpoint, the major change was the $65 million reduction in accounts payable. This change is also primarily caused by the lower revenue for the quarter. From a debt perspective, as of the end of the quarter we have $427 million in long-term debt. At the end of the quarter our gross leverage on total debt was approximately 1.4. Overall, our capital structure continues to be excellent and the best it has been in 13 years. Please turn to Slide 8 where we will review our balance sheet metrics. Cash is up $17 million from Q1. We're very comfortable with our cash at $408 million. The cash levels were higher than normal in Q3 and Q4 of last year as we were completing the debt refinancing. Cash flow from operations for the quarter were $70 million and net capital expenditures for the quarter were $17 million. This led to $53 million in free cash flow for the quarter. We expect to have positive free cash flow during the remainder of the fiscal year. Inventory levels were a disappointment in the second quarter. Inventory dollars were down $50 million from last quarter at $858 million, while the inventory turns were down to 6.4. It is clear that we did not reduce material purchases quickly enough to reflect the lower revenue levels. Compared to Q2 last year, inventory turns were also down 0.4 turns, but inventory dollars were up $58 million as a result of higher revenue. In the lower left quadrant we're showing cash cycle base which combines our cycle time for inventory, accounts receivable and accounts payable. Overall, cash cycle time increased from 40.1 days last quarter to 45.2 days. This change was driven by the 3.7 day increase in inventory and the 3.2 day increase in days sales outstanding. This increase was partially offset by a two-day increase in accounts payable days outstanding. Overall, cash cycle time continues to be respectable. In conclusion, return on invested capital decreased to 14.1% for the quarter, which was okay but not we want it to be or where it was over the last three quarters. Please turn to Slide 9. I would now like to share with you our guidance for the third quarter of fiscal year 2015. Our view is that revenue will be in the range of $1.5 billion to $1.55 billion. We expect that gross margin will be in the range of 7.6% to 8.0%. Operating expense should be $61 million to $63 million. This leads to an operating margin in the range of 3.5% to 3.9%. We expect that other income and expense will be in the range of $6 million to $7 million. And we expect the tax rate to be around 15%. And we expect our fully diluted share count to be around 86 million shares plus or minus half a million shares. When you consider all this guidance, we believe that you will end up with earnings per share in the range of $0.48 to $0.52. For your cash flow modeling we expect capital expenditures to be unusually large for Q3 at around $50 million. This is caused by an anticipated purchase of a building in June. The purchase of this building allows us to vacate leased space and reduce operating expenses going forward. Finally, depreciation and amortization will be around $25 million for the quarter. Overall, while our Q2 was a disappointment, particularly from a revenue standpoint, our profitability and cash generation were respectable. We will continue to diversify our revenue base to position ourselves solidly for the future. Growth continues to be our number one objective, but it is imperative that we grow with the right kind of profitable business. At this point I'll turn the discussion back over to Jure for more comments on our target markets and our business strategy.